In contrast, the therapeutic efficacy of NSAIDs in IMTs operates through different mechanisms, including vascular endothelial growth factor (VEGF) downregulation, cyclooxygenase-2 (COX-2) inhibition, and cytokine suppression which would target the inflammatory processes potentially driving tumor development [68]. This evidence concerns the gene VEGFA and neoplasm.